Barclays
CELU icon

Barclays’s Celularity CELU Stock Holding History

Barclays’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5 Buy
+4
New +$4 ﹤0.01% 5235
2023
Q2 		– Sell
-3,234
Closed -$20K – 4606
2023
Q1 		$20K Buy
3,234
+1,529
+90% +$12.3K ﹤0.01% 4658
2022
Q4 		$22K Buy
1,705
+1,419
+496% +$26.2K ﹤0.01% 4785
2022
Q3 		$7K Buy
286
+208
+267% +$6.31K ﹤0.01% 4414
2022
Q2 		$3K Buy
+78
New +$6.34K ﹤0.01% 4839

Other funds holding CELU

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Biltmore Family Office
Biltmore Family Office Charlotte, North Carolina $752M AUM 22.25% 1-Year Est. Return
HB Wealth Management
HB Wealth Management Atlanta, Georgia $19.5B AUM 16.96% 1-Year Est. Return
Sky Investment Group
Sky Investment Group Hartford, Connecticut $931M AUM 17.48% 1-Year Est. Return
IIA
IPG Investment Advisors San Diego, California $704M AUM 30.39% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
CoreCap Advisors
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
FP
Financial Perspectives Minneapolis, Minnesota $431M AUM 20.51% 1-Year Est. Return
Valley National Advisers
Valley National Advisers Bethlehem, Pennsylvania $909M AUM 22.39% 1-Year Est. Return
United Financial Planning Group
United Financial Planning Group Hauppauge, New York $199M AUM 14.18% 1-Year Est. Return

Barclays's CELU Position: Q3 2026 in Review

Barclays opened a new position in Celularity (CELU) in Q3 2026: 4 shares worth $5. The stake represents ﹤0.01% of the portfolio and ranks #5235 among its holdings. This is a return to the name: Barclays previously reported a position in CELU as recently as Q1 2023.

Barclays first reported a position in CELU in Q2 2022 and has held it in 5 quarters since. The position peaked at $22K in Q4 2022. 11 funds tracked by Wall St. Rank hold CELU as of Q3 2026.

  • Barclays held 4 shares of Celularity worth $5 as of Q3 2026.
  • Celularity was a new Barclays position in Q3 2026.
  • Celularity made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #5235 holding.
  • Barclays first reported a position in Celularity in Q2 2022 and has held it in 5 quarters since.
  • Barclays's Celularity position peaked at $22K in Q4 2022.
  • 11 funds tracked by Wall St. Rank held Celularity as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.